Shi, Yunhua
Reker, Daniel http://orcid.org/0000-0003-4789-7380
Byrne, James D.
Kirtane, Ameya R. http://orcid.org/0000-0002-3779-0363
Hess, Kaitlyn
Wang, Zhuyi
Navamajiti, Natsuda http://orcid.org/0000-0002-0346-1756
Young, Cameron C. http://orcid.org/0000-0001-7323-4834
Fralish, Zachary
Zhang, Zilu
Lopes, Aaron
Soares, Vance
Wainer, Jacob http://orcid.org/0000-0002-4845-228X
von Erlach, Thomas
Miao, Lei
Langer, Robert http://orcid.org/0000-0003-4255-0492
Traverso, Giovanni http://orcid.org/0000-0001-7851-4077
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (EB000244, EB000244)
Article History
Received: 9 November 2020
Accepted: 1 October 2023
First Online: 20 February 2024
Competing interests
: Y.S., D.R., V.S., R.L. and G.T. are co-inventors on a provisional patent application encompassing the work described. T.v.E., R.L. and G.T. have a financial interest in Vivtex, a biotechnology company applying ex vivo models for high-throughput drug formulation development. D.R. acts as a consultant to the pharmaceutical and biotechnology industry. Complete details of all relationships for profit and not for profit for G.T. and for R.L. can be found in the Supplementary Information.